Next Article in Journal
Changes in Choroidal Circulation Hemodynamics Measured Using Laser Speckle Flowgraphy after a Cold Pressor Test in Young Healthy Participants
Previous Article in Journal
The Efficacy of CT Temporal Subtraction Images for Fibrodysplasia Ossificans Progressiva
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Do We Need Another CT Scanner?—The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in Healthcare

1
Division of Health Economics and Healthcare Management, Kozminski University, 03-301 Warsaw, Poland
2
Ministry of Health, 00-952 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Tomography 2023, 9(2), 776-789; https://doi.org/10.3390/tomography9020063
Submission received: 23 February 2023 / Revised: 29 March 2023 / Accepted: 30 March 2023 / Published: 5 April 2023
(This article belongs to the Section Artificial Intelligence in Medical Imaging)

Abstract

:
Objectives: The purpose of this study was to assess the feasibility of the adoption of a machine learning (ML) algorithm in support of the investment decisions regarding high cost medical devices based on available clinical and epidemiological evidence. Methods: Following a literature search, the set of epidemiological and clinical need predictors was established. Both the data from The Central Statistical Office and The National Health Fund were used. An evolutionary algorithm (EA) model was developed to obtain the prediction of the need for CT scanners across local counties in Poland (hypothetical scenario). The comparison between the historical allocation and the scenario developed by the EA model based on epidemiological and clinical need predictors was established. Only counties with available CT scanners were included in the study. Results: In total, over 4 million CT scan procedures performed across 130 counties in Poland between 2015 and 2019 were used to develop the EA model. There were 39 cases of agreement between historical data and hypothetical scenarios. In 58 cases, the EA model indicated the need for a lower number of CT scanners than the historical data. A greater number of CT procedures required compared with historical use was predicted for 22 counties. The remaining 11 cases were inconclusive. Conclusions: Machine learning techniques might be successfully applied to support the optimal allocation of limited healthcare resources. Firstly, they enable automatization of health policy making utilising historical, epidemiological, and clinical data. Secondly, they introduce flexibility and transparency thanks to the adoption of ML to investment decisions in the healthcare sector as well.

1. Introduction

To ensure the optimal allocation of scarce healthcare resources, any public budget spending should be justifiable from the clinical, epidemiological, and financial perspectives. On the one hand, the planning of investments in healthcare infrastructure must consider timely patient access, limiting waiting times whenever possible. On the other, an excessive number of medical devices may induce the risk of over utilisation.
Across many jurisdictions, the conundrum of high demand vs. high cost exists in health policy planning and coordination mandated by law, particularly when public funds are involved. Thus far, there have been limited efforts with respect to the development of reimbursement schemes for high-cost medical equipment in a fashion similar to those already established for pharmaceuticals and high-risk medical devices. It is, therefore, prudent to ask whether there is an opportunity to introduce any new solutions to that problem in the era of growing data availability and AI-led methodological advancements. With this in mind, our study aimed to verify the feasibility of adapting a novel machine learning technique to the complex decision-making processes of health policy planning of high-cost medical devices. In particular, we sought to develop a data-driven support tool to optimise the allocation of computed tomography (CT) scans across geographical areas based on the assessment of clinical and epidemiological needs.
The reason for the choice of CT scans was twofold. Firstly, it is a versatile imaging technique with a growing range of applications. Second, over the years, it has become one of the most important diagnostic methods, allowing for the accurate diagnosis of multiple indications across different branches of medicine. Its advantages and widespread use have made CT a very popular imaging technique.
An evolutionary algorithm (EA) was chosen as the optimisation approach. EA is a flexible method derived from genetic algorithms (GAs) discovered in 1975 by Holland [1]. GAs were inspired by the process of biological evolution, including its many operators such as selection, crossover, and mutation. GAs and EAs are also used in medicine and healthcare research to solve different problems. However, to the best of our knowledge, evolutionary and GAs have not yet been used for the allocation of medical devices.

2. Data Sources

Given the access to the relevant datasets, Polish settings were chosen for the pilot study. The project was conducted under the framework of a research agreement between Kozminski University and the Polish Ministry of Health (MoH). The statistics of CT procedures were derived from the anonymised National Health Fund (NHF) database containing records of all healthcare services utilised in the public healthcare system between 1 January 2015 and 31 December 2019 (historical data on file). The analysis was limited to CT scan utilisation, that is, CT scan referrals and procedures. The frequency of CT procedures was calculated for each record using the assigned ICD-10 code. The number of CT scanners and waiting times were sourced from the Polish MoH websites [2]. Since the data analysis was conducted at the county level, the database was structured with 380 Polish counties according to the geographical administrative setup of the country. However, the five largest Polish cities (with more than 0.5 million inhabitants) were further divided into municipalities (city districts) for our analysis. A total of 32 municipalities were included. Only counties with more than one CT scanner were selected for the study.
The demographic data with geographical distribution were obtained from available national statistics (The Central Statistical Office).

3. Methods

The methodological approach involved two steps.
The first step was to define the CT’s need predictors. Following the approach of other researchers, a set of epidemiological and clinical need predictors was established [3,4].

3.1. Epidemiological CT Need Predictors

Following the approach of Kung, P. T. et al. [4], a set of epidemiological need predictors were selected, including county population, female to male ratio, and populations over 65 and under 14 years old. Data on family income at the county level were not available; hence, this was omitted from the list of predictors [4]. The data were derived from The Central Statistical Office [5]. If available, the latest data from 2019 were used. Otherwise, the most recent statistics were obtained, i.e., for Wrocław (2018), Łódź (2017), and Poznań (2018).
The analysis of each CT need predictor was conducted as follows: the counties were arranged in ascending order according to the length of the waiting time for the CT procedure and consequently divided into three groups (up to 25%, 25–75%, and above 75% of all counties). Basic statistics were separately calculated for all CT need predictors for each group.

3.2. Clinical CT Need Predictors

The core set of the 50 most frequently used ICD-10 codes (indications) that accounted for at least 40% of all CT procedures was used to establish the clinical need predictors. The number 50 was arbitrarily selected based on the review of all CT procedures conducted in the study period to identify the most accurate break-even point for ICD codes ranked from the most to the least often medical condition mentioned (TOP 50).
Subsequently, the most recent international and national radiological guidelines were adopted to verify the appropriateness of CT utilisation for each indication of the core set of 50 ICD-10 codes. The guidelines of the Polish Society of Oncology, the Polish Neurological Society, and the Association of Polish Surgeons were regarded as the primary references. The recommendations of the European Society for Medical Oncology, the European Association for Cardiothoracic Surgery, the European Alliance of Associations for Rheumatology, the European Association of Urology, the European Federation of Neurological Societies, the Global Initiative for Asthma, and the American Stroke Association were used if a particular indication was not found in Polish patients [6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33].
By adapting the appropriateness rating scale developed by the American College of Radiology (ACR) for radiological procedures, each of the most common 50 ICD-10 codes was further broken down into four categories:
  • Green—where CT use is ‘usually appropriate’;
  • Yellow—where CT use ‘may be appropriate’;
  • Red—where CT use is ‘usually not appropriate’.
The yellow category was assigned only when the ICD-10 code did not clearly indicate a specific medical condition, coding symptoms, or disorders not classified elsewhere. For each green indication, the number of patients was calculated at the county level to measure the clinical demand for CT scanners in the analysed areas.
The second step was to develop an EA model of evolutionary data.
A two-step approach was used to verify whether the machine learning algorithm has the ability to recommend a different scenario for CT scan utilisation compared with the actual one (historical data).
First, the EA was designed to determine a hypothetical scenario of the distribution of CT scanners across counties in 2019. The fitness function was developed with epidemiological need predictors and the number of patients referred for the CT procedure per county for the study period. The following steps were performed.
  • The generation of 100 chromosomes was calculated. Each chromosome represented a different scenario for the distribution of CT scanners across the country and consisted of 130 genes representing the number of CT scanners per county.
  • The fitness function for each generation of chromosomes was calculated. The proposed custom fitness gave a score for each chromosome by assessing its probability of meeting the defined need using the set of epidemiological and clinical indicators. A lower score was assigned if a given chromosome met each need indicator to the lowest extent possible. The function was constructed based on the principle of a weighted sum of mean squared error (MSE) values between a normalised (from 0 to 1) series of particular data corresponding to the proposed distribution of CT scanners. The formula for the fitness function is given as
    f fitness chromosome = w females p females +   w old p old +   w young p young +   w population p population +   w patients p patients
    where w x are weights for each x that is a CT need predictor, and p x values are defined as follows:
    p females = MSE v females ,   v scanners
    p old = MSE v old ,   v scanners
    p young = MSE v young , v scanners
    p population = MSE v population , v scanners
    p patients = MSE v patients , v scanners
    where v females , v old , v young , v population , v patients , and v scanners are a series of female ratios, elderly people ratios, young people ratios, populations, and the number of patients with referrals for CT procedures per county during the study period, respectively, all scaled into a range from 0 to 1, according to the following method:
    v i = v i min v max v min v
    where v i is the scaled i-th element of a vector, v i is the unscaled i-th element of the vector, and v is the entire vector. Initially, the authors assumed setting different values of weights for each aspect based on domain knowledge and a series of tests; however, the algorithm exhibited very low sensitivity to different weights. Therefore, all weights were the same for all aspects and were equal to 0.1.
  • The chromosomes included in the subsequent generation were selected based on ‘roulette wheel selection’, which took the fitness score into account. This method assumed that the likelihood of being selected was proportional to the ratio of the fitness function score of a given chromosome to the sum of the scores of the entire generation. The lower the score, the greater the likelihood of being selected for the next generation. Because the purpose of optimisation is to lower the fitness function, inverses of the fitness function values were used.
  • After choosing chromosomes for a new generation, crossover between randomly chosen chromosomes occurred. This mechanism allowed for the exchange of information between chromosomes within the previous generation. Chromosomes were chosen for crossover with a probability of 30% (as suggested in [34]). Specific genes were exchanged between two random chromosomes with a probability of 10% per gene. This number was assumed to achieve approximately 10% of the entire chromosome informational content exchanged.
  • Mutation was used as the subsequent mechanism, with a probability of 0.5% [34] per gene. A random number from the range −5–10 was added to the number of CT scanner mutations in each gene. This range was adopted after the initial analysis of the number of scanners across the population of the counties. The higher limit (10) was set to a value higher than the lower limit (−5) to make it possible for some counties to increase their numbers faster. In cases where the added number of CT scanners would result in a negative number, a zero value was entered. This completed the set of tasks conducted for each generation.
  • The procedures outlined in steps 1–5 were repeated until satisfactory results were obtained, that is, when the fitness function could not be decreased further. Previous tests showed that for particular settings, the number of generations was set to 1000.
Second, a feasibility study for the EA model was constructed to validate it against the available data on waiting time for the CT procedure. Counties were categorised into one of the following groups according to the following:
  • The groups of counties were ranked in ascending order from the shortest to the longest waiting times for a CT scan (waiting time = the number of waiting days).
  • Waiting times were divided into three groups:
    • Q1—waiting time ranging from 0 to 25% of the longest waiting time across included counties;
    • Q2—waiting time ranging from 25% to 75% of the longest waiting time across included counties;
    • Q3—waiting time ranging from 75% to 100% of the longest waiting time.
  • The counties were grouped into one of the following categories based on the difference between the historical number of CT scanners in a given county and the result from the EA model and additionally compared with the average waiting times to obtain CT scans for each county.
    • EA predicted a greater number of CT scans compared with historical data, and the average waiting time was in Q3—underinvestment of CT.
    • EA predicted a greater number of CT scans compared with historical data and the average waiting time was in Q2—potential for further development of equipment infrastructure.
    • EA predicted a lower number of CT scans compared with historical data, and the average waiting time was in Q3—potential for efficiency gains.
    • EA predicted a lower number of CT scans compared with historical data, and the average waiting time was in Q2—overuse of CT.
    • EA predicted a greater number of CT scans compared with historical data, but waiting times were at the average level in Q2—underuse of CT scanners.
    • EA predicted a lower number of CT scans compared with historical data, but waiting times were at the average level in Q2—overuse of CT scanners.
    • EA predicted a similar number of CT scans as that currently available in a given county.

4. Results

More than 4.7 million CT scans were used with at least one of the TOP 50 ICD codes, which is 41% of the total performed in the study period (January 2015–December 2019). The breakdown of CT procedures with respect to the green, yellow, and red categories is presented in Supplementary Table S1.
Only counties with at least one CT scanner were considered for the study. Out of 412 countries, only 130 were included. The descriptive characteristics with historical data on CT utilisation are presented in Table 1.
The pool of patients referred for the CT procedure was four times higher in the group of counties with the longest (Q3) vs. shortest (Q1) waiting time (Table 1). The average number of CT scanners per county was 3.1 and 8.7 for the group with the shortest (Q1) and longest (Q3) waiting time, respectively. The average size of the county population was 109,508 and 158,398 in the first and last groups, respectively (Table 1). In addition, the group of counties with the longest (Q3) waiting times had about two times more CT scans performed in comparison with the counties with the shortest (Q1) waiting times; on average, these were 15,192 and 37,023, respectively (Table 1).
The result of the EA model was a chromosome that achieved the lowest possible fitness score across all generations. Table 2 presents the results for each county. The number of iterations was stopped at 1000 generations, as further runs showed that the fitness function scores did not significantly decrease.
The descriptive characteristics of each of the seven groups are presented in Table 3. It should be noted that 11 counties were not assigned to any of the predefined groups (some of the counties were assigned to other categories, but due to the substantial insignificance of those categories, they were excluded from the analysis).
In the feasibility study, the results for 119 counties were included. Among these, there were 39 cases with EA predictions comparable to the historical data (Group G). In 58 counties (Groups C, D, and F), EA indicated a lower number of CT scans than the historical data. A greater need for CT examination compared with historical use was predicted in 22 counties. The results for all CT need predictors for each group are presented in Table 3.

5. Sensitivity Analysis

Sensitivity analysis with the chosen chromosome was conducted. Because randomness is strictly involved in evolutionary optimisation, the results were also affected.
An analysis of the sensitivity of weights also showed a low response of the results to changes in weights, which were initially assumed to vary to test different domain knowledge-based scenarios. Table 4 presents the results for different weight values and shows that the resulting values did not significantly differ from the previous ones, where all weights were equal to 0.1. The only exception is the scenario where the highest weight was applied to the population of counties. For this scenario, the results are noticeably different from other cases, which suggests that this factor should have the highest influence on the results.

6. Discussion

The purpose of this study was to assess the feasibility of adapting machine learning to decision-making regarding the allocation of high-cost diagnostic medical devices. The investment process with respect to computed tomography (CT) was chosen for that study. Access to CT scanners is considered vital for ensuring prompt and accurate diagnostics, allowing for timely treatment. Our analysis provided evidence that EAs may be a useful approach in that respect. Three interesting findings are worth highlighting.
First, the EA model was responsive to epidemiological need predictors for the allocation of CT scanners. When a similar number of CT scanners were predicted by the model as historical data (Categories A, E, and G), there was consistency with respect to key measures such as the mean, median, minimum, and maximum for each predictive variable.
Second, the EA model was validated against the waiting time for CT scans. It must be noted that waiting times were not used during the ML algorithm development. It was found that there is a tendency for EA to predict a greater number of CT scans in counties with longer waiting times. With a median of 63 days of waiting, EA indicated a median of five CT scanners per county compared with two CT scanners per county for a category with a median of six waiting days.
Third, our study proved that the adoption of the EA approach can aid allocative decisions by considering more determinants of the need for CT investment than waiting time alone. Interesting findings emerge from the comparison of Category G, which comprises counties with a historical number of CT scans similar to EA predictions against other groups. For example, Category C has epidemiological characteristics similar to those of Category G. Hence, EA predicted a similar number of CT scanners in both groups. However, the historical data clearly indicate that the number of CT scanners is greater than that predicted as optimal by EA in Category C. Thus, adding epidemiological predictors into decision-making can validate the rationale behind waiting times and even indicate potential efficiency gains in the case of underutilisation of available CT scanners. Interesting patterns with respect to both epidemiological and clinical need predictors were also observed for Categories G and E. In the latter, however, the mean values of the predictions were slightly higher, which justifies the greater number of CT scanners predicted by the EA model. The historical number of available CT scanners remained similar for both categories. In that particular example, it is noteworthy that the use of an algorithmic approach based on epidemiological predictions could support the decision to increase the allocation of CT scanners for counties in Category E, even though the current waiting times alone would not justify such a decision.
This study was not the first attempt to adopt EAs in the field of healthcare. However, there are examples of research efforts focusing on other types of problems. Gao et al. used evolutionary algorithms to diagnose bradykinesia in finger-tapping tests [35]. EAs were used to develop a classifier algorithm that correctly classified the test results of patients with early stage Parkinson’s disease. In 2019, Haddadene et al. successfully used a non-dominated sorting genetic algorithm for the first time to solve the vehicle routing problem for home healthcare for scheduling caregivers’ visits to their patients under specific conditions such as time, place, and patient preference [36]. The problem had the form of multi-objective combinatorial optimisation, with the first objective being minimising travel cost and the second objective being maximising patient satisfaction. He used evolutionary algorithms for the optimisation of resource allocation in the steel forging process [37]. The steel forging process can be described as a hybrid flow shop scheduling problem, and in that research, bi-objective evolutionary algorithms were successfully used along with real industrial data. Nanbin et al., in turn, used a hybrid system of greedy algorithms and GAs for resource allocation in the energy sector [38].
The problem of decision-making regarding the allocation of high-cost diagnostic medical devices has been addressed with different approaches. In 1978, Hosios et al. proposed a linear programming model that could be used by decision-makers for the allocation of radiographic equipment [39]. The production model of a diagnostic radiology department was created based on available data that included aspects such as medical and non-medical manpower (e.g., technicians or materials). Santibanez et al. used an integer programming model to solve the combinatorial optimisation problem of allocating radiation therapy centres based on geographic access in British Columbia, Canada [40]. Similarly, Czerwiński et al. used mixed-integer linear programming to allocate linear accelerators in Poland [41]. Tal et al. conducted questionnaire-based research among stakeholders of various medical-related backgrounds on aspects related to the allocation of expensive medical devices (EMD) [42]. The study showed that different criteria used for EMD allocation have different importance and, therefore, should be weighted differently in the decision-making process. A similar methodology was applied to the analysis of large medical equipment (LME) allocation in the Chinese province of Xuzhou in a study conducted by Miao et al. [43]. Research based on questionnaire answers received from local hospitals equipped with LME showed that the allocation of equipment was unfair.
Despite the uniqueness of our study, it is not free from limitations, at least five of which must be highlighted. First, only localities with more than one CT scanner were considered. The majority of counties (68.4%) had at most one CT scanner (97 localities had no CT scanners and 185 localities had only one CT scanner) and, thus, were excluded from the analysis. This approach was chosen to reduce the bias related to population distribution: such localities will usually have a relatively tiny population, but at the same time decrease heterogeneity (as larger differences in the selected demographic characteristics are expected between more urbanised and rural areas). Another important consideration is the practical difficulty of disinvestment if there is only one CT scanner in a particular county, as matters related to the distance for the patient and local policies play an important role.
Second, only 27 indications (identified by their ICD-10 codes) of the TOP 50 were considered in this study. The final analysis included indications that appeared in only 18% of all CT referrals. Exclusion of ICD-10 indications in which a CT scan did not constitute a standard of care was a key part of the analysis, which aimed at identifying clinical needs and not preserving current clinical practice. At the same time, it should be recognised that the database used in the analysis includes only one ICD-10 code for each contact (called the main ICD-10 code), where only a symptom of a disease constitutes the basis for referral (as the root cause of the symptom might be unknown at the time).
Third, 37 districts of the five largest cities (municipalities) were considered. Municipalities constitute 28% of all selected localities and have larger populations and a higher average number of CT scanners. Thus, an alternative approach to counties should be considered to ensure that the results better reflect patient mobility. The inclusion of city districts on par with counties leads to a situation where, in the case of two cities (i.e., Warszawa and Wroclaw), the algorithm suggests a larger number of CT scanners in some districts and an a smaller number in others. This effect is exacerbated when the concentration of care in large cities (e.g., major trauma centres and tertiary care centres) is taken into account. In the case of highly specialised healthcare providers, waiting times are sometimes significantly longer than in other nearby places (due to the provision of highly specialised care for the whole region). In this study, highly specialised care providers were not separately analysed.
Fourth, in this study, no consideration was given to differences in morbidity and mortality across regions. As some studies have shown that morbidity-based models may capture more adequate health needs than utilisation-based models, this aspect requires further research [44,45].
Finally, three demographic criteria reflecting the size of the population were considered. Although the choice of demographic indicators was influenced by the literature review, the possible impact of choosing three indicators closely related to the population (including the populations over 65 and under 14 years of age) is unknown and could be an avenue for further investigation.

7. Conclusions

The presented methodology shows how a variety of attributes may be included in the decision-making process in the healthcare sector. The ML algorithm offers an opportunity to simultaneously categorise clinical and epidemiological need predictors and even compare results with historical data. Our study indicates that it is possible to adopt ML for reimbursement decision-making in the healthcare sector. The use of a single broad fitness function allows different aspects to be considered and translated into one numerical value based on selected domain knowledge. The function takes as input locations to be supplied with a particular type of equipment and returns a single numerical value of how well a given combination suits the needs, which can be used to create a score for a particular combination of possible locations. For example, distance might be one aspect; therefore, geographical data along with health needs predictors should be used to define the optimal number of medical devices given the combination of attributes. Historical data from previous use of CT scanners can be used to validate the fitness function itself. The use of ML algorithms not only introduces an objective evidence-based approach to the reimbursement process, but also allows for flexibility and adaptability to the given decision-making problem. Our study demonstrates how such an approach can be introduced. Medical records coupled with clinical guidelines will help identify which criterion has the greatest influence on the use of a particular medical device. The fitness function will be later used with the basic form of the EA using crossover and mutation as operators. After a fixed number of iterations (generations), the algorithm finds the best approximated solution. It is therefore an evidence-based approach to decision-making encompassing a broad spectrum of attributes.
One advantage of the proposed approach towards the allocation of new investment in the decision-making process is the convenience of the easy interpretability of the final results. Our model produces a quantifiable result, such as a given number of CT scanners that should meet the demand driven by unmet medical needs in each of the selected geographical areas. Consequently, such an approach has the potential to be used as a supporting tool in many different allocation problems utilising basic statistics beyond the investigation of the CT scanners used in this particular study.
In summary, the introduction of ML algorithms in the decision-making process may provide many benefits to the healthcare system in general.
First, it may provide external validation of already adopted investment decisions as well as indicate the geographical regions with under supply or over supply of CT scanners. The latter may provide new opportunities to identify budget savings without reducing the level of healthcare in a particular area.
Second, it is a flexible method that allows us to add new variables in case there is a significant change in the situation in the country requiring adjustments to the model. It is worth mentioning that it is crucial to conduct continuous verification of the results to quantify the model’s accuracy. Additional information obtained from such an analysis would enable us to improve the model in the future.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/tomography9020063/s1, Table S1: TOP 50—The list ICD code qualified as Green (“usually appropriate”), Yellow (“may be appropriate”), Red (“usually not appropriate”).

Author Contributions

Conceptualization, K.K.; Methodology, K.K., G.K., M.W. and A.P.; Investigation, G.K., M.W., A.N., P.K.; writing—original draft preparation, K.K., G.K., A.N., P.K. and A.P.; writing—review and editing K.K. and A.P. Resources, M.W. involved in medical data preparation as well as producing input on the perspective of healthcare sector. A.P. has performed an assessment of indications for CT scans and A.N. and P.K. were involved in data preparation and prepared tables. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Restrictions apply to the availability of these data. Data was obtained from Ministry of Health, Poland and are available at request from the corresponding author with the permission of Ministry of Health, Poland.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Holland, J.H. Adaptation in Natural and Artificial Systems; University of Michigan Press: Ann Arbor, MI, USA, 1975. [Google Scholar]
  2. Available online: https://basiw.mz.gov.pl/ (accessed on 10 May 2020).
  3. Fuchs, S.; Grössmann, N.; Ferch, M.; Busse, R.; Wild, C. Evidence-based indications for the planning of PET or PET/CT capacities are needed. Clin. Transl. Imaging 2019, 7, 65–81. [Google Scholar] [CrossRef] [Green Version]
  4. Kung, P.T.; Tsai, W.C.; Yaung, C.L.; Liao, K.P. Determinants of computed tomography and magnetic resonance imaging utilization in Taiwan. Int. J. Technol. Assess. Health Care 2015, 21, 81–88. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Available online: https://bdl.stat.gov.pl/BDL/start (accessed on 14 August 2020).
  6. Polish Society of Oncology. 2019 Clinical Guidelines in Malignant Tumours. Available online: http://onkologia.zalecenia.med.pl/ (accessed on 25 May 2020).
  7. Krzakowski, M.; Jassem, J.; Antczak, A.; Chorostowska-Wynimko, J.; Dziadziuszko, R.; Głogowski, M.; Grodzki, T.; Kowalski, D.; Olszewski, W.; Orłowski, T.; et al. Cancer of the lung, pleura and mediastinum. Oncol. Clin. Pract. 2019, 15, 20–50. [Google Scholar] [CrossRef]
  8. Zyskowski, L.; Surowski, P.; Rutkowski, A.; Wieszczy, P.; Milewska, J.; Olesiński, T. Diagnostics and treatment of small intestine tumors in our own experience. Nowotw. J. Oncol. 2018, 68, 167–172. [Google Scholar]
  9. Wardas, P.; Markowski, J.; Piotrowska-Seweryn, A. Przegląd aktualnych wytycznych w zakresie diagnostyki i leczenia zapaleń zatok przynosowych z praktycznym komentarzem. Forum Med. Rodz. 2014, 8, 159–168. [Google Scholar]
  10. Dąbrowski, A. Choroby trzustki—Postępy 2017/2018. Med. Prakt. 2018, 7–8, 82–86. [Google Scholar]
  11. Wiszniewska, M.; Kobayashi, A.; Członkowska, A. Postępowanie w udarze mózgu Skrót Wytycznych Grupy Ekspertów Sekcji Chorób Naczyniowych Polskiego Towarzystwa Neurologicznego z 2012 roku. Pol. Przegląd Neurol. 2012, 8, 161–175. [Google Scholar]
  12. Brongel, L.; Hładki, W.; Karski, J.; Lasek, J.; Nogalski, A.; Słowiński, K. Postępowanie w przypadku urazów, Zalecenia Sekcji Urazów Towarzystwa Chirurgów Polskich. Med. Prakt. Chir. 2010, 5, 9–25. [Google Scholar]
  13. Skotnicka-Klonowicz, G.; Godziński, J.; Hermanowicz, A.; Wendland, J.; Strzesak, E.; Strzyżewski, K.; Czauderna, P. Postępowanie w lekkich i średniociężkich urazach głowy u dzieci–wytyczne Polskiego Towarzystwa Chirurgów Dziecięcych. Stand. Med./Probl. Chir. Dziecięcej 2014, 1, 42–50. [Google Scholar]
  14. Global Strategy for Asthma Management and Prevention. 2020. Available online: https://ginasthma.org/ (accessed on 25 May 2020).
  15. Knuuti, J.; Wijns, W.; Saraste, A.; Capodanno, D.; Barbato, E.; Funck-Brentano, C.; Prescott, E.; Storey, R.F.; Deaton, C.; Cuisset, T.; et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC). Eur. Heart J. 2020, 41, 407–477. [Google Scholar] [CrossRef] [Green Version]
  16. Türk, C.K.; Knoll, T.; Petrik, A.; European Association of Urology. Guidelines on Urolithiasis . 2015. Available online: http://uroweb.org/wp-content/uploads/22-Urolithiasis_LR_full.pdf (accessed on 10 May 2020).
  17. Casali, P.G.; Bielack, S.; Abecassis, N.; Aro, H.T.; Bauer, S.; Biagini, R.; Bonvalot, S.; Boukovinas, I.; Bovee, J.V.M.G.; Brennan, B.; et al. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2018, 29 (Suppl. 4), iv79–iv95. [Google Scholar] [CrossRef]
  18. Casali, P.G.; Abecassis, N.; Bauer, S.; Biagini, R.; Bielack, S.; Bonvalot, S.; Boukovinas, I.; Bovee, J.V.M.G.; Brodowicz, T.; Broto, J.M.; et al. Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2018, 29 (Suppl. 4), iv51–iv67. [Google Scholar] [CrossRef]
  19. Cardoso, F.; Kyriakides, S.; Ohno, S.; Penault-Llorca, F.; Poortmans, P.; Rubio, I.T.; Zackrisson, S.; Senkus, E. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2019, 30, 1194–1220. [Google Scholar] [CrossRef] [Green Version]
  20. Van Cutsem, E.; Cervantes, A.; Nordlinger, B.; Arnold, D. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2014, 25, iii1–iii9. [Google Scholar] [CrossRef]
  21. Glynne-Jones, R.; Wyrwicz, L.; Tiret, E.; Brown, G.; Rödel, C.D.; Cervantes, A.; Arnold, D. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017, 28, iv22–iv40. [Google Scholar] [CrossRef]
  22. Smyth, E.C.; Verheij, M.; Allum, W.; Cunningham, D.; Cervantes, A.; Arnold, D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2016, 27, v38–v49. [Google Scholar] [CrossRef]
  23. Ducreux, M.; Cuhna, A.S.; Caramella, C.; Hollebecque, A.; Burtin, P.; Goéré, D.; Seufferlein, T.; Haustermans, K.; Van Laethem, J.L.; Conroy, T.; et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2015, 26, v56–v68. [Google Scholar] [CrossRef]
  24. Gupta, M.; McCauley, J.; Farkas, A.; Gudeloglu, A.; Neuberger, M.M.; Ho, Y.Y.; Yeung, L.; Vieweg, J.; Dahm, P. Clinical practice guidelines on prostate cancer: A critical appraisal. J. Urol. 2015, 193, 1153–1158. [Google Scholar] [CrossRef]
  25. Colombo, N.; Peiretti, M.; Garbi, A.; Carinelli, S.; Marini, C.; Sessa, C.; ESMO Guidelines Working Group. Non-epithelial ovarian cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2012, 23, vii20–vii26. [Google Scholar] [CrossRef]
  26. Mandl, P.; Navarro-Compán, V.; Terslev, L.; Aegerter, P.; Van Der Heijde, D.; D’Agostino, M.A.; Baraliakos, X.; Pedersen, S.J.; Jurik, A.G.; Naredo, E.; et al. EULAR recommendations for the use of imaging in the diagnosis and management of spondyloarthritis in clinical practice. Ann. Rheum. Dis. 2015, 74, 1327–1339. [Google Scholar] [CrossRef]
  27. Vos, P.E.; Battistin, L.; Birbamer, G.; Gerstenbrand, F.; Potapov, A.; Prevec, T.; Stepan, C.A.; Traubner, P.; Twijnstra, A.; Vecsei, L.; et al. EFNS guideline on mild traumatic brain injury: Report of an EFNS task force. Eur. J. Neurol. 2002, 9, 207–219. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Filippi, M.; Agosta, F.; Barkhof, F.; Dubois, B.; Fox, N.C.; Frisoni, G.B.; Jack, C.R.; Johannsen, P.; Miller, B.L.; Nestor, P.J.; et al. EFNS task force: The use of neuroimaging in the diagnosis of dementia. Eur. J. Neurol. 2012, 19, 1487–1501. [Google Scholar] [CrossRef] [PubMed]
  29. Konstantinides, S.V.; Meyer, G.; Becattini, C.; Bueno, H.; Geersing, G.J.; Harjola, V.P.; Huisman, M.V.; Humbert, M.; Jennings, C.S.; Jiménez, D.; et al. 2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS). Eur. Heart J. 2020, 41, 543–603. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  30. Baumgartner, H.; Falk, V.; Bax, J.J.; De Bonis, M.; Hamm, C.; Holm, P.; Iung, B.; Lancellotti, P.; Lansac, E.; Rodriguez Muñoz, D.; et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur. Heart J. 2017, 38, 2739–2791. [Google Scholar] [CrossRef] [PubMed]
  31. Adler, Y.; Charron, P.; Imazio, M.; Badano, L.; Barón-Esquivias, G.; Bogaert, J.; Brucato, A.; Gueret, P.; Klingel, K.; Lionis, C.; et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur. Heart J. 2015, 36, 2921–2964. [Google Scholar]
  32. American College of Radiology Appropriateness Criteria—American College of Radiology. ACR Appropriateness Criteria®. Available online: https://acsearch.acr.org/list (accessed on 25 May 2020).
  33. Simmons, B.B.; Cirignano, B.; Gadegbeku, A.B. Transient ischemic attack: Part I. Diagnosis and evaluation. Am. Fam. Physician 2012, 86, 521–526. [Google Scholar]
  34. Michalewicz, Z. Genetic Algorithms + Data Structures = Evolution Programs; Springer: Berlin/Heidelberg, Germany, 1996. [Google Scholar]
  35. Gao, C.; Smith, S.; Lones, M.; Jamieson, S.; Alty, J.; Cosgrove, J.; Zhang, P.; Liu, J.; Chen, Y.; Du, J.; et al. Objective assessment of bradykinesia in Parkinson’s disease using evolutionary algorithms: Clinical validation. Transl. Neurodegener. 2018, 16, 7–18. [Google Scholar] [CrossRef] [Green Version]
  36. Haddadene, S.R.A.; Labadie, N.; Prodhon, C. Bicriteria Vehicle Routing Problem with Preferences and Timing Constraints in Home Health Care Services. Algorithms 2019, 12, 152. [Google Scholar] [CrossRef] [Green Version]
  37. Hsieh, T.J. Data-driven oriented optimization of resource allocation in the forging process using Bi-objective Evolutionary Algorithm. Eng. Appl. Artif. Intell. 2020, 89, 103469. [Google Scholar] [CrossRef]
  38. Xie, N.; Tian, J. Mixed Optimal Algorithm of Resource Allocation in Energy Industry. Energy Procedia 2011, 5, 322–331. [Google Scholar]
  39. Hosios, A.J.; Laszlo, C.A.; Levine, M.D. A Model to Support Radiographic Equipment Allocation Decisions. J. Oper. Res. Soc. 1978, 29, 205–214. [Google Scholar] [CrossRef]
  40. Santibanez, P.; Gauded, M.; French, J.; Liu, E.; Tyldesely, S. Optimal location of radiation therapy centers with respect to geographic access. Int. J. Radiat. Oncol. Biol. Phys. 2014, 89, 745–755. [Google Scholar] [CrossRef] [Green Version]
  41. Czerwiński, A.M.; Więckowska, B. Location-allocation model for external beam radiotherapy as an example of an evidence-based management tool implemented in healthcare sector in Poland. Radiother. Oncol. 2018, 127, 154–160. [Google Scholar] [CrossRef]
  42. Tal, O.; Sheffer, N.; Vaknin, S. Parameters for allocation of expensive medical devices (EMD) as a national regulatory mechanism. Harefuah 2008, 147, 359–362. [Google Scholar]
  43. Miao, C.X.; Zhuo, L.; Gu, Y.M.; Qin, Z.H. Study of large medical equipment allocation in Xuzhou. J. Zhejiang Univ. Sci. B 2007, 8, 881–884. [Google Scholar] [CrossRef] [Green Version]
  44. Vallejo-Torres, L.; Morris, S.; Carr-Hill, R.; Dixon, P.; Law, M.; Rice, N.; Sutton, M. Can regional resource shares be based only on prevalence data? An empirical investigation of the proportionality assumption. Soc. Sci. Med. 2009, 69, 1634–1642. [Google Scholar] [CrossRef]
  45. Asthana, S.; Gibson, A.; Moon, G.; Dicker, J.; Brigham, P. The pursuit of equity in NHS resource allocation: Should morbidity replace utilisation as the basis for setting health care capitations? Soc. Sci. Med. 2004, 58, 539–551. [Google Scholar] [CrossRef]
Table 1. General characteristics of the Polish utilization of CT scanners for 130 counties included in the study categorized into three groups by the waiting time for CT procedure (2019).
Table 1. General characteristics of the Polish utilization of CT scanners for 130 counties included in the study categorized into three groups by the waiting time for CT procedure (2019).
Waiting Time (Quartile, Range)Number of Counties (N) SumMean (SD)MinMax
Short (<Q1, 1–33)33Population of studied counties3,613,753109,507.7 (54,156)35,193297,554
% of female 52.0 (1.1)50.054.746
% of male 48.0 (1.1.)45.350.0
Above 65 years old691,16120,944.3 (10,463.4)565552,967
Below 14 years old526,18715,945.1 (8638.8)464845,189
Diagnosed with CT177,9415392.2 (5474.1)125225,340
Medium (Q1–Q2, 34–98)65Population of studied counties8,060,044124,000.724,513348,190
% of female 52.7 (1.2)49.955.0
% of male 47.3 (1.2)45.050.1
Above 65 years old1,630,87925,090.4 (15,423.1)399275,715
Below 14 years old1,223,93818,829.8 (9952.3)401150,032
Diagnosed with CT552,5368500.6 (9276.6)17143,420
Long (Q2–Q3, 99–130)32Population of studied counties5,068,719158,397.546,291470,907
% of female 52.4 (1.0)50.455.0
% of male 47.6 (1.0)46.249.6
Above 65 years old1,010,49731,578.0 (19,499.2)967696,394
Below 14 years old743,63023,238.4 (13,175.7)628572,801
Diagnosed with CT389,34012,166.9 (9214.3)202237,407
Short (<Q1, 1–33)33
Number of CTs1013.1 (2.0)213
Number of CT procedures501,33215,191.9 (21,253.3)201197,837
Number of CT procedures per patient80.22.4 (0.7)1.54.11
Number of patients waiting (urgent + stable cases)11,293342.2321169
Medium (Q1–Q2, 34–98)65
Number of CTs3064.7 (3.9)223
Number of CT procedures1,754,63926,994.4 (37,161.9)269208,486
Number of CT procedures per patient176.42.7 (0.7)1.54.8
Number of patients waiting (urgent + stable cases)102,6861579.8 (1411.6)100.04269
Long (Q2–Q3, 99–130)32
Number of CTs2778.7 (9.1)228
Number of CT procedures1,184,73537,023.0 (32,218.1)4049129.82
Number of CT procedures per patient88.92.8 (0.6)1.73.9
Number of patients waiting (urgent + stable cases)39,9551248.6 (1036.9)414914
Table 2. Number of CT scanners determined by the EA model (best chromosome) per each county (2019).
Table 2. Number of CT scanners determined by the EA model (best chromosome) per each county (2019).
County’s CodeCounty’s NameNumber of CT Scanners Obtained from AlgorithmCurrent Number of CT Scanners
0202dzierzoniowski33
0206jeleniogórski12
0208kłodzki12
0211lubiński33
0219świdnicki22
0225zgorzelecki32
0261City-Jelenia Góra23
0262City-Legnica42
0264049City-Wroclaw-Psie Pole District4ND
0264069City-Wroclaw-Srodmiescie District1ND
0264059City-Wroclaw-Old Town District6ND
0264039City-Wroclaw-Krzyki District4ND
0264029City-Wroclaw-Fabryczna District4ND
0264City-Wroclaw1918
0461City-Bydgoszcz618
0462City-Grudziądz13
0463City-Toruń46
0464City-Włocławek33
0614puławski33
0661City-Biała Podlaska32
0662City-Chełm22
0663City-Lublin621
0664City-Zamość24
0804nowosolski22
0807sulęciński32
0808świebodziński23
0811żarski22
0861City-Gorzów Wielkopolski43
0862City-Zielona Góra43
1003laski32
1008pabianicki52
1016tomaszowski33
1017wieluński12
1019zduńskowolski22
1020zgierski35
1021brzeziński11
1061059City-Lodz-Śródmieście District28
1061069City-Lodz-Widzew District415
1061029City-Lodz-Baluty District610
1061039City-Lodz-Gorna District611
1061049City-Lodz-Polesie District59
1205gorlicki12
1207limanowski22
1211nowotarski24
1217tatrzański42
1261029City-Krakow-Krowodrza District68
1261039City-Krakow-Nowa Huta District66
1261049City-Krakow-Podgorze District74
1261059City-Krakow-Srodmiescie District414
1262City-Nowy Sącz22
1263City-Tarnów24
1405grodziski42
1407kozienicki02
1417otwocki25
1418piaseczyński54
1428sochaczewski32
1433węgrowski32
1462City-Płock13
1463City-Radom38
1464City-Siedlce13
1465078City-Warsaw-Praga Południe District311
1465168City-Warsaw-Wilanów District42
1465058City-Warsaw-Mokotow District515
1465158City-Warsaw-Wesoła District20
1465028City-Warsaw-Bemowo District40
1465198City-Warsaw-Żoliborz District35
1465098City-Warsaw-Rembertów District20
1465068City-Warsaw-Ochota District413
1465048City-Warsaw-Bielany District45
1465038City-Warsaw-Białołeka District20
1465128City-Warsaw-Ursus District21
1465088City-Warsaw-Praga Północ District25
1465138City-Warsaw-Ursynów District411
1465148City-Warsaw-Wawer District54
1465108City-Warsaw-Śródmieście District611
1465188City-Warsaw-Wola District34
1465178City-Warsaw-Włochy District31
1465118City-Warsaw-Targówek District52
1604kluczborski02
1802brzozowski24
1811mielecki32
1816rzeszowski22
1818stalowowolski22
1861City-Krosno22
1862City-Przemyśl32
1863City-Rzeszów312
2061City-Białystok711
2063City-Suwałki02
2202chojnicki12
2206kościerski22
2207kwidzyński22
2215wejherowski25
2261City-Gdańsk811
2262City-Gdynia63
2263City-Słupsk23
2401będziński42
2403cieszyński26
2405gliwicki23
2411raciborski42
2413tarnogórski52
2416zawierciański42
2461City-Bielsko-Biała36
2462City-Bytom56
2463City-Chorzów32
2464City-Częstochowa46
2465City-Dąbrowa Górnicza43
2466City-Gliwice45
2469City-Katowice618
2471City-Piekary Śląskie12
2473City-Rybnik22
2475City-Sosnowiec55
2477City-Tychy22
2478City-Zabrze54
2607ostrowiecki22
2610skarżyski22
2661City-Kielce39
2861City-Elbląg33
2862City-Olsztyn610
3017ostrowski32
3019pilski23
3020pleszewski22
3061City-Kalisz32
3062City-Konin33
3063City-Leszno23
3064049City-Poznan-Nowe Miasto District29
3064059City-Poznan-Stare Miasto District311
3064039City-Poznan-Jezyce District311
3064029City-Poznan-Grunwald16
3064069City-Poznan-Wilda District22
3261City-Szczecin44
3262City-Świnoujście1011
Note: ND means no data.
Table 3. Descriptive characteristic of the studied Polish counties grouped into one of the seven categories based on the difference between the historical number of CT scanners in a given county and the results of the EA model and compared with historical average CT waiting times (2019).
Table 3. Descriptive characteristic of the studied Polish counties grouped into one of the seven categories based on the difference between the historical number of CT scanners in a given county and the results of the EA model and compared with historical average CT waiting times (2019).
Female Ratio (%)Under 14 Years Old (%)Population over 65 (%)County PopulationCT Procedures CT Scanners- EA Model CT Scanners—Historical DataWaiting Time
Group A (underinvestment of CT) (n = 9 counties)
Mean0.53 0.15 0.21 145,609 7596 4.89 3.67 69
Median0.53 0.14 0.21 124,992 6513 5.00 3.00 64
Min.0.52 0.11 0.17 78,244 1505 4.00 2.00 48
Max.0.55 0.18 0.25 246,348 15,349 6.005.00122
Group B (potential for further development of the equipment infrastructure) (n = 3 counties)
Mean0.510.150.1991,64136813.502.506.96
Median0.510.150.1991,64136813.502.506.96
Min.0.500.140.1635,19322373.002.005.00
Max.0.520.160.21148,08951244.003.008.92
Group C (potential for efficiency gains) (n = 35 counties)
Mean0.530.160.19156,43611,6603.569.4461.56
Median0.530.150.20131,29685413.005.0053.45
Min.0.500.120.0924,5131710.002.0047.89
Max.0.550.260.24483,78938,89610.0028.00129.12
Group D (overproduction of CT) (n = 5 counties)
Mean0.510.150.1898,247 30831.402.806.24
Median0.510.150.1876,25628592.003.006.00
Min.0.510.130.1755,79012520.002.003.92
Max.0.520.160.18178,19165692.004.009.14
Group E (underconsumption of CT scans) (n = 10 counties)
Mean0.530.150.19146,31969544.503.0018.38
Median0.520.150.19129,90542784.003.0012.74
Min.0.510.100.1547,02813804.002.0011.93
Max.0.550.190.25308,07024,0766.004.0040.23
Group F (overconsumption of CT scans) (n = 18 counties)
Mean0.520.150.19222,15716,4813.008.4429.86
Median0.520.150.19182,75891062.506.0028.84
Min.0.510.120.1464,76026610.002.0012.74
Max.0.540.200.27495,35043,4207.0023.0047.03
Group G (n = 39 counties)
Mean0.520.150.19137,81361902.792.7725.64
Median0.520.150.19136,11249313.002.0026.11
Min.0.500.120.1330,83313241.002.0010.00
Max.0.550.190.29300,59027,3486.006.0046.95
Unclassified (n = 11 counties)
Mean0.510.150.18136,67047282.152.1543.22
Median0.510.150.18139,94637902.002.0048.42
Min.0.500.130.1563,01414832.002.004.94
Max.0.520.170.21253,14213,1283.003.00114.34
Table 4. Results of the weight sensitivity analysis—number of localities distributed to group A–G in runs of the model based on changed weights.
Table 4. Results of the weight sensitivity analysis—number of localities distributed to group A–G in runs of the model based on changed weights.
Need Predictor WeightsNumber of Localities in Particular Groups
Population sizeFemale ratioAged >64Aged <14CT patientsGroup AGroup BGroup CGroup DGroup EGroup FGroup G
0.50.10.10.10.194364111640
10.10.10.10.1153314101839
0.10.50.50.50.114630391939
0.11110.1155306111343
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Kolasa, K.; Kozinski, G.; Wisniewska, M.; Pohadajlo, A.; Nosowicz, A.; Kulas, P. Do We Need Another CT Scanner?—The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in Healthcare. Tomography 2023, 9, 776-789. https://doi.org/10.3390/tomography9020063

AMA Style

Kolasa K, Kozinski G, Wisniewska M, Pohadajlo A, Nosowicz A, Kulas P. Do We Need Another CT Scanner?—The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in Healthcare. Tomography. 2023; 9(2):776-789. https://doi.org/10.3390/tomography9020063

Chicago/Turabian Style

Kolasa, Katarzyna, Grzegorz Kozinski, Maria Wisniewska, Aleksandra Pohadajlo, Agata Nosowicz, and Piotr Kulas. 2023. "Do We Need Another CT Scanner?—The Pilot Study of the Adoption of an Evolutionary Algorithm to Investment Decision Making in Healthcare" Tomography 9, no. 2: 776-789. https://doi.org/10.3390/tomography9020063

Article Metrics

Back to TopTop